A Comparative Analysis of Post-market Surveillance for Natural Health Products (NHPs)

A Comparative Analysis of Post-market Surveillance for Natural Health Products (NHPs)

Show other versions (1)

Natural health products (NHPs) are attractive due to the public’s perception that they are natural and safe but there is wide variety of risks associated with these products. Post-market surveillance is the key to control hazards produced from NHPs. A set of activities are involved in post-market su...

Full description

Bibliographic Details
Main Author:	Kaur, Suman D.
Language:	en
Published:	2013
Subjects:	Post-market surveillance Natural Health Products NHPs Comparative Analysis Herbal Medicines Pharmacovigilance Adverse Drug Reactions Adverse Reactions Post-market Surveillance Best Practices Post-market Surveillance Framework Scoring Scheme Canadian NHP Post-market Surveillance System International Practices for NHPs Post-market Surveillance
Online Access:	http://hdl.handle.net/10393/30254

Similar Items

A Comparative Analysis of Post-market Surveillance for Natural Health Products (NHPs)
by: Kaur, Suman D.
Published: (2013)

The Potential Role of Social Media in Pharmacovigilance in Nepal: Glimpse from a Resource-limited Setting
by: Sunil Shrestha, et al.
Published: (2019-03-01)

Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study
by: Pasquale Stefanizzi, et al.
Published: (2021-05-01)

Post-approval Surveillance on Safety and Clinical Utility of Garenoxacin Mesylate in Patients with Community Acquired Respiratory Tract Infections
by: Himanshu Garg, et al.
Published: (2018-01-01)

Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population
by: Contreras-Salinas H, et al.
Published: (2021-05-01)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)

Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances
by: Yoshifumi Inoue, et al.
Published: (2021-01-01)

Challenges Associated with the Safety Signal Detection Process for Medical Devices
by: Pane J, et al.
Published: (2021-02-01)

A Machine Learning-Aided Framework to Predict Outcomes of Anti-PD-1 Therapy for Patients With Gynecological Cancer on Incomplete Post-Marketing Surveillance Dataset
by: Xiaomei Liu, et al.
Published: (2021-01-01)

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
by: Hiroshi Inoue, et al.
Published: (2016-04-01)

Protektivitas, Reaksi Lokal dan Sistemik Pascaimunisasi dengan Vaksin Campak (Bio Farma) dari Bets Vaksin yang Berbeda pada Anak Sekolah Dasar di Sumatera Barat
by: Julitasari Sundoro, et al.
Published: (2015-09-01)

Protektivitas, Reaksi Lokal dan Sistemik setelah Imunisasi dengan Vaksin Td pada Anak Sekolah Dasar di Indonesia
by: Julitasari Sundoro, et al.
Published: (2014-09-01)

National post-market surveillance assessment of veterinary medicines in Korea during the past decade
by: JeongWoo Kang, et al.
Published: (2017-05-01)

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
by: Noriko Nakamura, et al.
Published: (2021-07-01)

A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India
by: Praveen Chandra, et al.
Published: (2014-11-01)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT)
by: Kazunori Utsunomiya, et al.
Published: (2021-02-01)

Profil Keamanan setelah Pemberian Dosis Primer Vaksin Pentabio® pada Bayi di Indonesia
by: Julitasari Sundoro, et al.
Published: (2017-06-01)

Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus
by: Kozono H, et al.
Published: (2018-01-01)

Scientific Opinion on the use of existing environmental surveillance networks to support the post‐market environmental monitoring of genetically modified plants
by: EFSA Panel on Genetically Modified Organisms (GMOs)
Published: (2014-11-01)

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study
by: Hideyasu Matsuyama, et al.
Published: (2020-07-01)

Safety of laboratory analyzers for infection testing - results of the market surveillance by the BfArM until end 2007
by: Siekmeier R, et al.
Published: (2009-12-01)

Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019-07-01)

Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance
by: Yuna Sugimoto, et al.
Published: (2021-04-01)

Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report
by: Terao T, et al.
Published: (2017-06-01)

Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine
by: Linlu Zhao, et al.
Published: (2021-05-01)

Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA
by: Yuxi Jia, et al.
Published: (2019-08-01)

Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
by: Hirohito Shimizu, et al.
Published: (2020-02-01)

Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection
by: Tripathi S, et al.
Published: (2019-10-01)

A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero
by: Helen Petousis-Harris, et al.
Published: (2019-10-01)

Physician-Related Variability in the Outcomes of an Invasive Treatment for Neck and Back Pain: A Multi-Level Analysis of Data Gathered in Routine Clinical Practice
by: Ana Royuela, et al.
Published: (2021-04-01)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
by: Kazuo Kawasugi, et al.
Published: (2021-02-01)

Assessment of the usefulness of anti-Wb123 antibody for post-elimination surveillance of lymphatic filariasis
by: Ameyo Monique Dorkenoo, et al.
Published: (2021-01-01)

Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017
by: Zhiqun Li, et al.
Published: (2020-10-01)

General Surveillance for Effects of GM Crops on the Soil Ecosystem (Poster Presentation at the 4<sup>th</sup> International Workshop on PMEM of Genetically Modified Plants, Quedlinburg, Germany 2010)
by: Eric Smit, et al.
Published: (2011-07-01)

Levofloxacin: Insights Into Antibiotic Resistance and Product Quality
by: Ensieh Izadi, et al.
Published: (2019-08-01)

SYSTEMATIC USE OF CAUSALITY ASSESSMENT IN AEFI SURVEILLANCE: A 2013-2016 PILOT STUDY IN PUGLIA
by: Pasquale Stefanizzi
Published: (2017-10-01)

From malaria elimination to post‐elimination: a 10-year surveillance data study in Shanghai
by: Simin Dai, et al.
Published: (2021-04-01)

Epidemiology and surveillance of human animal-bite injuries and rabies post-exposure prophylaxis, in selected counties in Kenya, 2011–2016
by: Jeremiah Ngurimu Ngugi, et al.
Published: (2018-08-01)

Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients
by: Shinichi Suzuki, et al.
Published: (2019-02-01)

Phase IV of Drug Development
by: Viraj Suvarna
Published: (2010-01-01)